Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0231528 (
myalgia
)
6,565
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In a joint effort of the Israel Center for Disease Control, the National Center for
Influenza
in the Central Virology Laboratory, together with a group of collaborating pediatricians and family physicians, a network for
influenza
surveillance was established in the winter of 1996-97. Nose and throat swabs were obtained from 571 patients with
flu
-like illness. 133 (23%) were positive for
influenza
virus. Both
influenza
A(H3N2) and B were isolated, predominantly
influenza
B during the beginning of the season. Both circulating strains were antigenically similar to those included in the vaccine for 1996-1997. Patients from whom
influenza
virus was isolated were significantly more likely to suffer from cough and
myalgia
in comparison with patients whose cultures were negative (p = 0.02 and 0.003, respectively). Results of the first year of surveillance indicate that sentinel reporting clinics are useful for timely detection and identification of the viral strains circulating in the community, thus allowing prompt intervention in preventing the spread of
influenza
. Conclusions from the first year of the study were drawn and applied in the winter of 1997-1998.
...
PMID:[Use of sentinel reporting clinics for influenza surveillance in the winter of 1996-1997]. 1091 92
In 1997, passengers on North American cruises developed acute respiratory illnesses (ARIs);
influenza
was suspected. We reviewed 1 ship's medical records for 3 cruises: cruise 1 (31 August to 10 September 1997), cruise 2 (11-20 September 1997), and cruise 3 (20-30 September 1997). Medically attended ARI was defined as any 2 of the following symptoms: fever (temperature, > or =37.8 degrees C) or feverishness, sore throat, cough, nasal congestion, chills,
myalgia
, and arthralgia. During cruise 2, we collected nasopharyngeal swabs for viral culture from people with ARI and surveyed passengers for self-reported ARI (defined as above except feverishness was substituted for fever). The outbreak probably began among Australian passengers on cruise 1 (relative risk, 3.3; 95% confidence interval, 1.89-5.77). Of 1284 passengers on cruise 2, 215 (17%) reported ARI, 994 (77%) were aged > or =65 years, and 336 (26%) had other risk factors for respiratory complications. An
influenza
strain not previously identified in North America was isolated. We concluded that an "off-season"
influenza
outbreak occurred among international travelers and crew on board this cruise ship.
...
PMID:Cruise ships: high-risk passengers and the global spread of new influenza viruses. 1098 1
A prospective study was conducted to find the incidence and clinical manifestations of
influenza
in 201 nurse assistant students of Faculty of Tropical Medicine during June 1998 to May 1999. There were 106 episodes of
influenza
-like illness (incidence 52.7%) of which only 33% were proven to be
influenza
(incidence 17.4%). Main clinical manifestations of
influenza
included headache, fever, malaise,
myalgia
, rhinorrhea, cough, and sore throat. We found that
influenza
could not be diagnosed solely by using clinical manifestations. Respiratory pathogenic bacteria were rarely isolated in patients with
influenza
-like illness and this led to our suggestion that routine pharyngeal culture and antibiotic therapy would not be helpful.
Influenza
vaccination of every nurse assistant student would be beneficial.
...
PMID:Incidence and clinical manifestations of influenza in nurse assistant students. 1102 65
Combined pharyngeal and nasal swab specimens were collected from 100 subjects who presented with a
flu
-like illness (fever >37.8 degrees C plus 2 of 4 symptoms: cough,
myalgia
, sore throat, and headache) of <72 hours' duration at 3 different clinics in the province of Quebec, Canada, during the 1998-1999
flu
season. The rate of laboratory-confirmed
influenza
infection was 72% according to cell culture findings and 79% according to the results of multiplex reverse-transcription polymerase chain reaction (RT-PCR) analysis (85%,
influenza
AH3; 15%,
influenza
B). All subjects for whom these results were discordant (negative culture and positive PCR) presented with a temperature > or =38.2 degrees C as well as 3 or 4 of the symptoms in the clinical case definition. Stepwise logistic regression showed that cough (odds ratio [OR], 6.7; 95% confidence interval [CI], 1.4-34.1; P=.02) and fever (OR, 3.1; 95% CI, 1.4-8.0; P=.01) were the only factors significantly associated with a positive PCR test for
influenza
. The positive predictive value, negative predictive value, sensitivity, and the specificity of a case definition including fever (temperature of >38 degrees C) and cough for the diagnosis of
influenza
infection during this
flu
season were 86.8%, 39.3%, 77.6%, and 55.0%, respectively.
...
PMID:Predicting influenza infections during epidemics with use of a clinical case definition. 1107 47
An outbreak of
Influenza
A virus occurred in a hilltribe village between July 18th and August 8th, 1997. The overall infection rate was 92.5 per cent. The household infection rate was higher in the crowded part of the village. The symptoms analyzed after all, were fever (100%), cough (99%), headache,
myalgia
(78.1%) and rhinorrhea (50.5%). The patients were self - recovery within 5-7 days. Isolation and Haemagglutination inhibition test (HI) were undertaken to identify the causative agent. The results were positive for
influenza
A/Wuhan/359/95(H3N2) - like strain. The outbreak did not spread to the town, possibly because of the differences in environmental condition. Predisposing factors of the village that may have influenced the outbreak were crowded living quarters, cold (8 - 10 degrees C) and moist weather, poor personal hygiene and improper sanitation.
...
PMID:An outbreak of Influenza A virus in a hilltribe village of Mae Hong Son Province Thailand, 1997. 1107 65
Bryostatin 1 (bryo 1) is an example of a novel class of anticancer drug which modulates protein kinase C (PKC) activity. It has varied biological effects mediated largely by the initial activation of PKC, followed by its rapid downregulation. Bryo 1 stimulates in vitro and in vivo haematopoietic progenitor cell growth in a concentration-dependent and lineage-specific fashion. Granulocytes, lymphocytes, monocytes and platelets are all functionally stimulated by bryo 1. Stimulation of cytotoxic T-cell activity by bryo 1 has led to research utilising bryo 1 as an immunotherapeutic agent in mouse tumour xenograft models. The clinical development of bryo 1 followed the demonstration of direct in vitro activity against various tumour cell lines. Multiple Phase I trials have shown
muscle pain
and
flu
-like symptoms are the most common toxicities associated with administration of bryo 1. There is particular interest in the role of bryo 1 in haematologic malignancies because of its capacity to induce leukaemic cell differentiation. There is ample in vitro data demonstrating that bryo 1 can sensitise tumour cells to cytotoxic agents. Recent clinical work has focused on combining bryo 1 with traditional chemotherapeutic agents for both haematologic and non-haematologic cancers.
...
PMID:Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug. 1113 48
To determine whether some constitutional symptoms of
influenza
, such as headache,
myalgia
and nausea, could represent a viral infection of brain, muscle, and liver, we inoculated juvenile Balb/c mice intranasally with 103 plaque forming units of
influenza
B/Lee virus. Blood, brain, liver, skeletal muscle, and lung tissues were removed aseptically and assayed for infectivity by a plaque assay, viral RNA by reverse transcriptase-polymerase chain reaction (RT - PCR), viral antigen by immunoperoxidase staining, and histologic changes by light microscopy. Mice became ill 2 - 3 days post inoculation (PI). A productive viral infection of the lungs developed from days 1 - 8 with maxima of virus titers, pneumonia, and the number of immunoperoxidase staining lung cells occurring on days 2 - 6 PI. Virus isolation from blood was rare and viral RNA was detected intermittently in blood by RT - PCR. In many animals, a non-permissive or abortive infection of brain occurred from days 1 - 8 and peaked on days 3 - 4 PI. Viral RNA was detected in brain tissue and viral antigen was seen in cerebral endothelial cells but infectious virus was rarely isolated from brain. In liver, viral RNA was detected and viral antigen was seen occasionally in hepatocytes. In skeletal muscle, viral RNA was detected but neither infectious virus nor viral antigen was seen. A correlation existed between the severity of the illness, pneumonia, lung virus titer, viral antigen in lung cells, and extent of a non-permissive viral infection of brain and liver but not muscle. These studies demonstrate that following intranasal infection of
influenza
virus in mice, a viral pneumonia develops with subsequent intermittent viremia and non-permissive or abortive infection of brain, liver and muscle.
...
PMID:Experimental influenza causes a non-permissive viral infection of brain, liver and muscle. 1117 25
Influenza
A pneumonia accounts for a significant number of the community-acquired pneumonias in the United States. While
myalgia
is a common complaint in
influenza
A infection, few cases of rhabdomyolysis associated with this virus have been described. Although it has been recently recognized that rhabdomyolysis complicating certain bacterial pneumonias has important prognostic implications, rhabdomyolysis in the setting of
influenza
A pneumonia does not appear to carry the same prognostic significance.
...
PMID:Influenza A pneumonia with rhabdomyolysis. 1121 46
Sildenafil citrate (Viagra) has been shown to be an effective treatment for erectile dysfunction (ED) of organic aetiology. This study assessed the efficacy and tolerability of sildenafil for treating ED of psychogenic and mixed psychogenic/organic aetiology. Men with ED of psychogenic and mixed aetiology were randomised in a double-blind, fixed-dose study to placebo (n = 95) or sildenafil 10 mg (n = 90), 25 mg (n = 85), or 50 mg (n = 81) once daily for 28 days. Efficacy was evaluated with two global efficacy questions, a patient log of erectile activity, a sexual function questionnaire and a partner questionnaire. Patients receiving sildenafil had significantly more grade 3 (hard enough for penetration) or grade 4 (fully hard) erections per week than patients receiving placebo, and a greater proportion of patients receiving sildenafil reported that treatment had improved their erections (p < 0.001). Results of the sexual function questionnaire demonstrated significant improvement for patients with ED receiving sildenafil compared with patients receiving placebo for frequency, hardness and duration of erections (p < 0.01), and for enjoyment of sexual intercourse and satisfaction with sex life (p < 0.05). The results of the partner questionnaire were consistent with the results reported by patients and showed that treatment with sildenafil was associated with significant improvement in the partners' own sex lives (p < 0.001). Adverse events were mostly mild to moderate in nature. The commonest adverse events were headache, dyspepsia, flushing,
myalgia
, arthralgia and
flu
syndrome. Discontinuations due to treatment-related adverse events were few, ranging from 1.1% to 6.2% for patients receiving different doses of sildenafil and 4.2% for patients receiving placebo. Sildenafil is an effective and well-tolerated treatment for ED of psychogenic or mixed aetiology with once-daily dosing.
...
PMID:Sildenafil citrate (Viagra) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology. 1122 Sep 82
Myositis and rhabdomyolysis with
influenza
are rare, but sometimes serious complications. Patients with myositis more commonly have
influenza
B infection than
influenza
A. On the other hand, rhabdomyolysis are more frequently recognized in patients with
influenza
A infection than those with
influenza
B. Upper respiratory symptoms usually precede myositis, while rhabdomyolysis occurs simultaneously or shortly after the respiratory symptoms. Creatine kinase levels are elevated in myositis mildly and in rhabdomyolysis markedly.
Influenza
myositis improve spontaneously within 6 weeks, but
influenza
rhabdomyolysis sometimes induce renal failure with fatal outcome. Although the true incidence of myositis and rhabdomyolysis in the
influenza
infection remains unknown, careful medical care is necessary when patients have
muscle pain
and weakness.
...
PMID:[Myositis and rhabdomyolysis with influenza infection]. 1122 17
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>